“Management of Bleeding Events and Invasive Procedures in Patients With Haemophilia A Without Inhibitors Treated With Emicizumab: A Consensus Statement of the Working Party on Haemostasis of the Swiss Society of Haematology and the Swiss Haemophilia Network”. 2020. Swiss Medical Weekly 150 (5153): w20422. https://doi.org/10.4414/smw.2020.20422.